FDA Advisory Committee Split on SGLT 1/2 Inhibitor for T1D

(MedPage Today) -- Sotagliflozin ' s DKA risk daunts panel members in 8-8 vote

Source: MedPage Today Nephrology - January 17, 2019 Category: Urology & Nephrology Source Type: news